Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2005
08/25/2005US20050186279 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit
08/25/2005CA2556159A1 Methods of modulating neurotrophin-mediated activity
08/25/2005CA2556086A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
08/25/2005CA2555848A1 Antibody targeting osteoclast-associated protein
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2555151A1 New synbiotic use
08/25/2005CA2554748A1 External preparation for treating painful skin wound
08/25/2005CA2554378A1 Bicycloamide derivative
08/24/2005EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
08/24/2005EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use
08/24/2005EP1565475A1 Diazinopyrimidines
08/24/2005EP1565456A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/24/2005EP1565453A1 2- (4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565431A1 Cannabinoid receptor ligands
08/24/2005EP1565215A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565183A1 Rapamycin and il-10 for the treatment of immune diseases
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1372624B1 Tramadol-based medicament
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1204426B1 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
08/24/2005EP1187803B1 Amorphous nitric esters and their pharmaceutical compositions
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005EP1143925B1 Topical composition comprising n-acetylglucosamine
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1072266B1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
08/24/2005EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
08/24/2005CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens
08/24/2005CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments
08/24/2005CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
08/24/2005CN1658893A G-type peptides to ameliorate atherosclerosis
08/24/2005CN1658886A Hormone replacement therapy
08/24/2005CN1658885A Hormone replacement therapy
08/24/2005CN1658881A Anti-inflammatory compositions and methods of use
08/24/2005CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
08/24/2005CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
08/24/2005CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
08/24/2005CN1658863A Severe sepsis preventive therapeutic agent
08/24/2005CN1658857A NF-kB activation inhibitors
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/24/2005CN1658854A Immunity-related protein kinase inhibitors
08/24/2005CN1658852A Amidine derivatives for treating amyloidosis
08/24/2005CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
08/24/2005CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s)
08/24/2005CN1658837A Dry powder inhalant composition
08/24/2005CN1657095A Chinese herbal medicinal powder for treating atrophic arthritis
08/24/2005CN1657090A Extract of prinsepia wood and its bioactivity function
08/24/2005CN1657088A Medicinal composition for treating rheumatism atrophic arthritis
08/24/2005CN1657087A Medicinal composition for treating rheumatism atrophic arthritis
08/24/2005CN1657086A Medicinal composition for treating rheumatism atrophic arthritis
08/24/2005CN1657076A Medicinal incense possessing health-care function
08/24/2005CN1657068A Chinese-medicinal plaster for external wound
08/24/2005CN1657041A Skin penetration absorption preparation
08/24/2005CN1657040A Curcumin and phosphatide composite and its preparation method
08/24/2005CN1657039A Dry adhesive plaster of powdered ointment
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1215867C Broad-spectrum anti-inflammatory, antiviral Chinese medicine preparation and preparing method thereof
08/24/2005CN1215857C Medicine for treating cow mammitis
08/24/2005CN1215855C Externally applied medicine for stopping itching, relieving pain and eliminating swelling
08/24/2005CN1215846C Use of 2a, 23-dihydroxyl ursolic acid in preparing the anti-inflammatory agent
08/24/2005CN1215838C Declofenac sodium pastes and preparation thereof
08/23/2005US6933386 Process for preparing certain pyrrolotriazine compounds
08/23/2005US6933314 Integrin receptor inhibitors
08/23/2005US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933303 Antidiabetic agents
08/23/2005US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders
08/23/2005US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini
08/23/2005US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy